CHEK2 and cancer: In this study, our hunch for small molecule inducers of Chk2 found out a potential lead from Withaferin A isoxazoline derivatives (W-2b) that phosphorylates Chk2 (T68) and induces its expression in two rapidly proliferating cancer cells from diverse tissue origin (MCF7 and HCT-116).